ArticleFrontiers in radiology2025
Diagnostic challenges of gliosarcoma: case report of a rare glioblastoma histopathological variant.
Article in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gliosarcoma of the right cerebellar hemisphere and parahippocampal region: A case report and literature review.Oncology letters · 2026Article
- Multiplanar MRI approach to the differential diagnosis of central nervous system tumors and tumor-like lesions in patients with HIV: what radiologists need to know.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: According to the 5th revision of World Health Organization (WHO) of central nervous system tumors classification, gliosarcoma is a malignant tumor grade 4 and is the rarest and aggressive subtype of isocitrate dehydrogenase (IDH) wild-type glioblastoma. The special histopathological feature of the tumor is its biphasic differentiation including both the glial and the sarcomatous (mesenchymal) components of the tumor. The characteristics mentioned above create difficulties in radiological and histological diagnoses. Because of its rarity, gliosarcoma is typically not even considered in the differential diagnosis. Case presentation: This clinical case study describes a 55-year-old man exhibiting acute right-sided hemiparesis and disorientation for 12 h with loss of consciousness. A brain МRI of the patient revealed an intracerebral mass in the left frontoparietal area with close relationship with the dura mater, ring-like enhancement, severe perifocal edema, restricted diffusion of the solid component, internal vascular shunts, microhemorrhages, and elevated perfusion values. At the preoperative stage, the differential diagnosis included glioblastoma, solitary metastasis, and the possibility of an anaplastic meningioma. Tumor microsurgical resection was performed. According to the results of histological and immunohistochemical studies, gliosarcoma was diagnosed. Discussion: The only characteristic gliosarcoma feature was the phenomenon of solid node heterogeneity detected on the conventional T2-weighted sequence: a combination of hypo- and hyperintense parts. While multiparametric magnetic resonance imaging (MRI) aids in differentiating high-grade gliomas, metastases, and meningiomas, gliosarcoma remains underrecognized because of overlapping features. The observed T2 heterogeneity may serve as a potential radiological marker for gliosarcoma. Accurate and timely identification of brain tumor type is required to establish the appropriate extent of resection in surgical planning. Conclusion: This case publication does not intend to ignore the data of conventional sequences and instead considers them to be included in the structure of the multiparametric MRI protocol. However, larger studies are needed to validate the findings of this case study and refine diagnostic criteria for this rare tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.